Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
483.00    2.40 (0.50%)
Bid:
482.80
Ask:
483.40
Spread: 0.60 (0.124%)
Market Cap: £2.49b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Directorate Change

21 Mar 2019 07:00

RNS Number : 5031T
QinetiQ Group plc
21 March 2019
 

QinetiQ Group plc Directorate Change. Non-executive Director Appointment.

Mark Elliott to retire as Chairman in July 2019

Neil Johnson appointed to succeed him

21 March 2019 - QinetiQ Group plc today announced the appointment of Neil Johnson as an independent Non-executive Director to the QinetiQ Board with effect from 2 April 2019. Neil will assume the role of Chairman when Mark Elliott retires from the QinetiQ Board at the conclusion of the Annual General Meeting on 24 July 2019. On appointment, Neil will become a member of the Audit, Remuneration, Nominations, Risk & CSR, and Security Committees.

Neil Johnson has extensive Board experience and is currently Chairman of the FTSE250 global polymers and specialist chemicals company Synthomer. Until March 2017 he also chaired defence technology company e2v technologies.

After Sandhurst and the Army, Neil spent much of his early career in the automotive and engineering industries. He was worldwide Sales and Marketing Director at Jaguar before being seconded to the UK Ministry of Defence to command 4th Battalion The Royal Green Jackets with an operational role in Germany. After the three-year secondment, he returned to industry with British Aerospace, initially running Land Rover and then all of its European automotive operations. Neil was later CEO of the RAC where he managed the demutualisation and sale process.

For the past seven years, Neil has been Senior Independent Director of the Business Growth Fund. He is also a former Director General of the Engineering Employers Federation and was a Home Office appointed Independent Member of the Metropolitan Police Authority in the years running up to the London Olympics in 2012.

Michael Harper, Senior Independent Director, who led the process to appoint a successor to Mark said:

"We undertook a rigorous, independent search for candidates who could enhance the delivery of our vision for QinetiQ, and provide the right support and constructive challenge to our executive team. We are delighted that Neil Johnson will be joining us. He is a former CEO and seasoned plc Chairman, and has experience in defence, with both Army service and later as an advisor to the UK Ministry of Defence.

"On behalf of the Board I would like to thank Mark for the significant contribution he has made to QinetiQ over the past ten years during which time he has overseen the rebuilding of our balance sheet and implementation of a strategy to deliver long-term and sustainable growth."

Mark Elliott said:

"It has been a great privilege to chair QinetiQ during a period of considerable change. The Company has a renewed strategic focus and a strong executive team. With his extensive and varied boardroom experience, Neil Johnson is a tremendous choice to be my successor. I look forward to welcoming him to the Board when he joins in April."

Neil Johnson said:

"I am delighted to be joining the Board of QinetiQ and to be succeeding Mark in due course. During his successful tenure, sound foundations have been laid for the future development of the business. I will be joining a Company whose performance is gathering momentum thanks to a clear strategy, strong leadership and a robust balance sheet. The future is exciting for QinetiQ and I am looking forward to working with the Board of Directors and the executive team."

Neil Johnson other appointments

Neil Johnson retires from his role as Chairman of Motability Operations Group plc at the end of March 2019, having served nine years on the Board.

It has also been announced that Neil will step down as Chairman of Centaur plc prior to becoming QinetiQ Chairman in July 2019.

Since May 2016, Neil has been Chairman of Electra plc, the former private equity firm which has returned more than £2bn to its shareholders during this period. As agreed by shareholders, Electra is now running off its final few investments and reducing overheads prior to closing the fund once that process has been successfully concluded.

He remains Chairman of Synthomer plc, the global polymers and specialist chemicals business, and is Senior Independent Director at the Business Growth Fund.

9.6.11R and 9.6.13R of the Listing Rules of the UK Listing Authority

This notice is given in fulfilment of the obligation under paragraph 9.6.11R of the Listing Rules. There are no further details that are required to be disclosed in respect of Neil Johnson's appointment under paragraph 9.6.13 of the Listing Rules.

S430(2B) Companies Act 2006

Mark Elliott has not and will not receive any loss of office payments, nor will he be paid any further remuneration for his service as a Director of QinetiQ Group plc, other than fees due for his services up to the date he leaves.

Fees

Neil Johnson's fees will be £49,000 per annum payable from 2 April 2019. Upon his appointment as Chairman his fees will be £250,000 per annum.

About QinetiQ:

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence, security and critical infrastructure markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

David Bishop, Group Director Investor Relations and Communications:

+44 (0) 7920 108675

Ian Brown, Group Head of Investor Relations:

+44 (0) 7908 251123

Jon Hay-Campbell, Group Head of Communications

+44 (0) 7500 856953

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADBLFLKXFLBBB
Date   Source Headline
10th Jun 20265:09 pmRNSDirector/PDMR Shareholding
10th Jun 202611:05 amRNSAnnual Financial Report
9th Jun 20265:00 pmRNSHolding(s) in Company
9th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20266:00 pmRNSHolding(s) in Company
2nd Jun 20267:00 amRNSTransaction in Own Shares
29th May 20264:45 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSQinetiQ Full Year Results 2026
20th May 20264:16 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20264:57 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20269:46 amRNSTransaction in Own Shares
30th Apr 20263:10 pmRNSTotal Voting Rights
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20261:38 pmRNSDirector Declaration
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:00 pmRNSDirector/PDMR Shareholding
7th Apr 202610:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSDirector/PDMR Shareholding
31st Mar 20263:01 pmRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 202611:39 amRNSHolding(s) in Company
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 202612:30 pmRNSDirector/PDMR Shareholding
10th Mar 202612:30 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.